Causes of Thrombocytopenia
Primary Mechanism-Based Classification
Thrombocytopenia results from four fundamental mechanisms: decreased platelet production, increased platelet destruction, splenic sequestration, or dilution/clumping. 1, 2
Decreased Platelet Production
- Bone marrow disorders including myelodysplastic syndromes, leukemias, and other malignancies impair megakaryocyte function and platelet release 1
- Bone marrow suppression occurs with chronic alcohol use, certain medications, viral infections (HIV, hepatitis C, parvovirus, CMV), and iron overload 1, 3
- Aplastic anemia presents with pancytopenia (anemia, thrombocytopenia, and neutropenia) due to hypocellular marrow with fatty replacement 4
- Inherited thrombocytopenias such as thrombocytopenia-absent radius syndrome, Wiskott-Aldrich syndrome, MYH9-related disease, and 22q11.2 deletion syndrome affect platelet production from birth 1
Increased Platelet Destruction
Immune-Mediated Destruction
Primary immune thrombocytopenia (ITP) is an autoimmune disorder with antibody-mediated destruction of otherwise normal platelets, diagnosed only after excluding all secondary causes 1, 3
Secondary immune thrombocytopenia is associated with multiple conditions 1:
- Autoimmune diseases (systemic lupus erythematosus, antiphospholipid syndrome)
- Viral infections (HIV, hepatitis C, CMV)
- Lymphoproliferative disorders
- Common variable immune deficiency
- Bone marrow transplantation
- Vaccination side effects
Drug-induced immune thrombocytopenia can occur with antibiotics, GPIIb-IIIa inhibitors, quinine, sulfonamides, vancomycin, cefazolin, oxacillin, clindamycin, doxycycline, and SMX-TMP, typically presenting 5-14 days after drug exposure 1, 5
Heparin-induced thrombocytopenia (HIT) typically presents with moderate thrombocytopenia (30-70 × 10⁹/L) occurring 5-10 days after heparin initiation, paradoxically associated with thrombosis rather than bleeding 1
Non-Immune Destruction
- Thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and HELLP syndrome cause platelet consumption through microvascular thrombosis 1, 2
- Disseminated intravascular coagulation (DIC) causes consumption of platelets and coagulation factors through widespread fibrin and platelet deposition 1
- Antiphospholipid syndrome causes thrombocytopenia with thrombosis, not bleeding 1
- Consumption thrombocytopenia occurs with extracorporeal circuits, intra-aortic balloon pumps, and cardiac surgery with cardiopulmonary bypass 1
Splenic Sequestration
- Hepatic disease with portal hypertension leads to splenomegaly and increased platelet sequestration 2, 6
- Up to one-third of total platelet mass can be sequestered in an enlarged spleen 6
Special Populations
Neonates and Children
- Neonatal alloimmune thrombocytopenia occurs when maternal antibodies cross the placenta and destroy fetal platelets 7
- Inherited thrombocytopenias may present in the neonatal period with characteristic features such as large platelets or associated congenital anomalies 1, 7
Pregnancy
- Gestational thrombocytopenia is the most common cause in pregnancy, typically presenting with mild thrombocytopenia (platelet count >70 × 10⁹/L) 1
- Pregnancy-induced hypertension/preeclampsia and HELLP syndrome can cause severe thrombocytopenia requiring emergency intervention 1
Cyanotic Congenital Heart Disease
- Polycythemia and hyperviscosity trigger platelet consumption, with platelet counts inversely correlating with hematocrit levels, resulting in mild thrombocytopenia (100,000-150,000/μL) more commonly than severe 1
Critical Diagnostic Pitfalls to Avoid
- Pseudothrombocytopenia from EDTA-dependent platelet clumping can falsely lower counts; always exclude by examining peripheral blood smear and repeating count in heparin or sodium citrate tubes 1, 2
- Missing secondary causes of ITP (HIV, hepatitis C, H. pylori) which have different natural histories and responses to therapy; test all adults with suspected ITP regardless of risk factors 1, 3
- Overlooking drug-induced thrombocytopenia; obtain detailed medication history including over-the-counter medications and herbal supplements 1
- Failing to recognize HIT early; calculate 4T score immediately if patient has received any heparin within the past 3 months 1
- Delaying recognition of thrombotic microangiopathies (TTP/HUS) which require prompt diagnosis and treatment to prevent catastrophic outcomes 1